RadioVal was featured in the European Congress of Radiology 2024 held in Vienna, Austria, as part of the session “Artificial Intelligence (AI); real impact: redefining clinical decision making based on medical images“ on March 3rd, 2024.
Prof. Oliver Diaz, RadioVal Project Coordinator, from the University of Barcelona, delivered a presentation showcasing RadioVal’s latest results, marking a significant step towards the international clinical validation of Radiomics-based AI tools for breast cancer treatment planning.
Additionally, he introduced the FUTURE-AI guideline aimed at ensuring trustworthy AI implementation in breast cancer care. The session was a great success and resulted in a lively discussion with attendees during the Q&A session.
To watch the session recording, follow these simple steps:
- Visit the session page on ESR Connect and select the session you would like to attend.
- Click on “Login” in the upper right corner and enter your ESR MyUserArea credentials or create a new ESR account for free (please visit the session page once again after you have created your account).
- The session is now saved in your user menu under “My courses,” which can be accessed via the user icon in the upper right corner.
- When the session starts, log into your account and visit the session page, where the livestream will start automatically.
EIBIR, the communication and dissemination partner of RadioVal, was present during the entire duration of the ECR, informing interested participants at the booth about RadioVal and its mission to transform cancer care for breast cancer patients through radiomics-based Artificial Intelligence tools. These tools empower and protect breast cancer patients by providing them personalised treatment related to their illness.
RadioVal is looking forward to being part of ECR2025 and continuing to contribute to validating AI solutions in breast cancer treatment!